Healthcare provider profile · identity verified

Andrew Herman, MD

Internal Medicine · CANTON, OH · NPI 1801859004

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	637	188
Levothyroxine Sodium	Levothyroxine Sodium	512	144
Losartan Potassium	Losartan Potassium	486	146
Amlodipine Besylate	Amlodipine Besylate	466	133
Atorvastatin Calcium	Atorvastatin Calcium	367	110
Lisinopril	Lisinopril	356	100
Pantoprazole Sodium	Pantoprazole Sodium	337	93
Omeprazole	Omeprazole	295	80
Metformin Hcl	Metformin Hcl	253	64
Metoprolol Succinate	Metoprolol Succinate	244	62
Hydrochlorothiazide	Hydrochlorothiazide	220	64
Pravastatin Sodium	Pravastatin Sodium	220	58
Carvedilol	Carvedilol	207	54
Potassium Chloride	Potassium Chloride	185	61
Metoprolol Tartrate	Metoprolol Tartrate	179	44
Simvastatin	Simvastatin	179	48
Furosemide	Furosemide	173	56
Clopidogrel	Clopidogrel Bisulfate	164	37
Fluticasone Propionate	Fluticasone Propionate	136	59
Allopurinol	Allopurinol	134	38
Metformin Hcl Er	Metformin Hcl	134	37
Tamsulosin Hcl	Tamsulosin Hcl	132	35
Trazodone Hcl	Trazodone Hcl	126	31
Sertraline Hcl	Sertraline Hcl	125	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	117	36
Albuterol Sulfate Hfa	Albuterol Sulfate	115	68
Eliquis	Apixaban	108	29
Gabapentin	Gabapentin	92	31
Jardiance	Empagliflozin	89	26
Synthroid	Levothyroxine Sodium	84	25
Fluoxetine Hcl	Fluoxetine Hcl	76	24
Montelukast Sodium	Montelukast Sodium	76	24
Valsartan	Valsartan	74	18
Ezetimibe	Ezetimibe	73	19
Famotidine	Famotidine	70	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	21
Atenolol	Atenolol	59	17
Spironolactone	Spironolactone	59	15
Ramipril	Ramipril	55	12
Glimepiride	Glimepiride	51	16
Amoxicillin	Amoxicillin	49	42
Tizanidine Hcl	Tizanidine Hcl	49	13
Meloxicam	Meloxicam	47	14
Buspirone Hcl	Buspirone Hcl	46	11
Esomeprazole Magnesium	Esomeprazole Magnesium	46	17
Clonidine Hcl	Clonidine Hcl	45	15
Xarelto	Rivaroxaban	45	12
Donepezil Hcl	Donepezil Hcl	44	11
Finasteride	Finasteride	44	11
Hydralazine Hcl	Hydralazine Hcl	44	12
Hydroxyzine Hcl	Hydroxyzine Hcl	42	19
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Warfarin Sodium	Warfarin Sodium	36	13
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Glipizide	Glipizide	35	12
Azithromycin	Azithromycin	34	27
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Prednisone	Prednisone	29	24
Bupropion Xl	Bupropion Hcl	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	24
Glipizide Er	Glipizide	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Cephalexin	Cephalexin	24	20
Chlorthalidone	Chlorthalidone	24	suppressed
Folic Acid	Folic Acid	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Sucralfate	Sucralfate	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Linzess	Linaclotide	20	suppressed
Methylprednisolone	Methylprednisolone	20	18
Probenecid	Probenecid	20	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Bumetanide	Bumetanide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	13
Benazepril Hcl	Benazepril Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Ozempic	Semaglutide	14	suppressed
Praluent Pen	Alirocumab	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Estradiol	Estradiol	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Olanzapine	Olanzapine	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error